Editorial Policies

Neoplasia Research has constructed the below editorial policies in accordance with the instructions by the Committee on Publication Ethics (COPE). We shape our publishing platform to comply with the Best Practice Guidelines of the committee and follow its Code of Conduct.

Copyright Ownership:

For all works published by the neoplasia research, authors reserve ownership of the copyright for their article, but allow all readers to download, reuse, reprint, modify, distribute, and/or copy articles in the journals by Neoplasia research provided the original authors and source are appropriately cited.

All Submissions to our journals must be original work, the copyright to which is not previously owned by anyone, elsewhere. Genuine and innovative work is always welcomed along with a strong encouragement for cross- disciplinary approaches. It is the corresponding authors' responsibility to check for possible copyright conflict with the copyright holder and agree to our Publication Ethics and Publication Malpractice Statement.

No Parallel Publication:

When a manuscript is submitted to our journals for consideration parallel submissions of same material, in whole or in part, elsewhere are not allowed; posting of same manuscript on authors institutional website also falls under this restriction. If a case of such subsequent submission comes under publishers knowledge, we reserve the right to withdraw publishing rights from authors and co-authors of the article for a substantial time.

Authorship of the Article:

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. No responsibilty lies on Neoplasia research regarding the authorship matters including their names or the order of the authors list in case of articles where we sense any dispute regarding the authorship matter Neoplasia research reserves the right of not publishing that article. The participants who have contributed in certain substantive aspects of the research project, should be acknowledged or listed as contributors. If the article is submitted by a group of researchers, at least one of them should be identified by name and for being responsible for communications related to manuscript publication and for responding to inquiries, if any, about the published article. This author's name and contact information is required be presented as the Corresponding Author on the title page.

Corresponding Authorship:

The corresponding author is the author responsible for communicating with the journal for publication related matters. The corresponding author should ensure that all author agree to be the co-authors, accept their order of names as listed in the submitted article and agree on the content of the article and its submission for publication and have approved the final version of the paper.

Plagiarism Policy:

There is no space for any form of plagiarized material in our journals.

It is noteworthy that all articles submitted to Neoplasia Research are subjected to plagiarism check (copying of any material) on submission. Professionally-recognized soft wares (including CROSS CHECK and PLAGIARISM CHECKER X) are used to evaluate all submissions. Authors are instructed to assure the journal about following this policy by providing proper citation of any directly quoted material whether in text form, images, data or ideas. Articles may be highly prone to major revisions or even rejection if their amount of similarity index to other articles in our database is found greater than the allowed limits. We make sure to check the articles for plagiarism just after their submission however, in rare cases of detection of plagiarism after publication of the article, a correction may be issued or the publisher reserves the right tp retract the paper and inform the authors institutions about their decision to do so.

Disclosure and Conflicts of Interest

All authors should disclose any financial or another substantive conflict of interest in their manuscript that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Each submitted article should include a statement about it even when there are no conflicts to disclose.


The Editor in Chief/editors and any editorial staff must not disclose any information about a submitted manuscript and its content to anyone else other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher.

Informed Consent

Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. A patient who is identifiable must be shown the manuscript to be published. In case of clinical studies, case reports or patient data presentation it is mandatory that the identifying details of patients should be omitted if they are not essential. If identifying details are required to be published, the patients must be shown the manuscript before publication, in case of altered details with the purpose of protecting patients identity, authors should provide assurance that the alterations do not change the results or conclusions of this paper and Editors should be informed. When informed consent has been obtained, it should be clearly mentioned in the manuscript.

Peer Review Policy

All journals published by Neoplasia Research follow the peer review system designed for each submitted article. Manuscript topics are normally approved by senior editors followed by formal peer review conducted in collaboration with editorial board members and independent professionally skilled referees appointed by editorial team of each journal.

Articles are double- blinded reviewed, on receiving the comments from the reviewers, Senior Editors make decisions as to whether the paper must be directly rejected or sent to the authors for revision. After receiving the revised copy of the manuscript, it is sent to the reviewers for their approval or additional comments. If further revision is required by the reviewer the article is sent to the authors for a second round of revision according to the reviewers suggestions. Only 3 rounds of revision are allowed for any manuscript before its final publication.

In case of theme issue on a particular topic, the appointed Guest Editor is responsible to conduct peer review and submit full review reports along with accepted manuscripts of the journal.

Neoplasia Research encourages its editorial teams to use the electronic submission and peer-review system for its journals to facilitate them during peer review process.